Entoptica, a spin-off of CEVR, has been awarded the Grand Award in the Hong Kong ICT Startup Award - Hardware and Device Category, while their product, the SLOPE (Structured Light Observation Perception and Evaluation) device, has received the prestigious Gold Award from the judging panel. The company was founded by Dr. Mukhit Kulmaganbetov, Co-founder & CEO, and Mr. Taranjit Singh, Co-founder & CTO.
It is a tremendous honor to receive the Grand Award from Prof. Sun Dong, JP, Secretary for Innovation, Technology, and Industry. We are especially grateful that Mr. Paul Chan, GBM, GBS, MH, JP, Financial Secretary, and Prof. Sun Dong visited our booth to learn more about SLOPE. Dr. Peter Pang, General Manager of CEVR, introduced the device, and they expressed great interest in our technology.
The SLOPE system is transforming the screening process for age-related macular degeneration (AMD) by enabling early detection through a quick, two-minute test that does not require pupil dilation, ensuring a comfortable experience for patients.
The judging panel praised SLOPE for its technological innovation and potential societal impact. By leveraging quantum technology in vision sciences, Entoptica offers a rapid, non-invasive, and more affordable alternative to traditional methods, enhancing accessibility to early diagnostics, especially in underserved communities.
The Hong Kong ICT Awards (HKICTA) recognizes and promotes outstanding ICT inventions and applications. This initiative encourages innovation and excellence among Hong Kong’s ICT talent and enterprises in their constant pursuit of creative and effective solutions to meet business and social needs.
Established in 2006 through collaborative efforts from industry, academia, and the Government, the HKICTA is organized by the Digital Policy Office of the Hong Kong Special Administrative Region and led by local ICT industry associations and professional bodies. The awards aim to build a respected and internationally recognized brand in ICT.
We take pride in this recognition as we strive to improve healthcare solutions on a global scale!
At CEVR, we are leveraging translational research to develop advanced technologies for commercialization, aiming to enhance healthcare outcomes and improve the quality of life for individuals worldwide. Together, we look forward to achieving further advancements!
For more information of SLOPE, visit: https://www.entoptica.co/
